Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
WHO said in a statement that while it's not known whether Ervebo may protect against the Bundibugyo virus, "early laboratory and animal data suggest it may provide some protection."
PBS NewsHour2 sources
Published by CurrentWire · First coverage · Latest coverage
Compiled by CurrentWire News Desk
Summary based on reporting from PBS NewsHour and Global News.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
2 publications are covering this story.
Excerpts are the summaries each publisher distributes with its own feed, shortened and attributed.
PBS NewsHourTier A
Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks(opens original report in a new tab)Global NewsTier B
Congo to receive 70K doses of Ervebo Ebola vaccine used in past outbreaks(opens original report in a new tab)The Ervebo vaccine is licensed for use against Ebola virus, one of the viruses that cause Ebola disease, but not for Bundibugyo virus. — Global News
How coverage developed
First report from Global News
Reported by PBS NewsHour
How CurrentWire compiled this story
PBS NewsHour (www.pbs.org), a Tier A publisher, filed this report on . CurrentWire published this page 24 hours later, on .
Signal breakdown
CurrentWire ranked this story 45.5 of 100 in the snapshot this page was rendered from.
- Freshness
- 5.5 of 35
- Source authority
- 20 of 20
- Coverage breadth
- 8.5 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: source authority, 20 of 20. How each signal is calculated.
Filed under Health · International · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: Ervebo Ebola (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.